Does BOTULINUM TOXIN TYPE A Cause Peripheral swelling? 461 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 461 reports of Peripheral swelling have been filed in association with BOTULINUM TOXIN TYPE A (Jeuveau). This represents 12.3% of all adverse event reports for BOTULINUM TOXIN TYPE A.
461
Reports of Peripheral swelling with BOTULINUM TOXIN TYPE A
12.3%
of all BOTULINUM TOXIN TYPE A reports
439
Deaths
387
Hospitalizations
How Dangerous Is Peripheral swelling From BOTULINUM TOXIN TYPE A?
Of the 461 reports, 439 (95.2%) resulted in death, 387 (83.9%) required hospitalization, and 377 (81.8%) were considered life-threatening.
Is Peripheral swelling Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BOTULINUM TOXIN TYPE A. However, 461 reports have been filed with the FAERS database.
What Other Side Effects Does BOTULINUM TOXIN TYPE A Cause?
Off label use (1,785)
Drug ineffective (1,175)
Drug intolerance (1,004)
Product use in unapproved indication (950)
Headache (797)
Migraine (775)
Maternal exposure during pregnancy (716)
Pain (714)
Hypoaesthesia (703)
Nausea (665)
What Other Drugs Cause Peripheral swelling?
ADALIMUMAB (13,837)
ETANERCEPT (12,654)
METHOTREXATE (10,632)
TOCILIZUMAB (8,030)
TOFACITINIB (7,830)
ABATACEPT (7,561)
LEFLUNOMIDE (7,254)
LENALIDOMIDE (6,364)
HYDROXYCHLOROQUINE (6,128)
RITUXIMAB (5,977)
Which BOTULINUM TOXIN TYPE A Alternatives Have Lower Peripheral swelling Risk?
BOTULINUM TOXIN TYPE A vs BREMELANOTIDE
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB
BOTULINUM TOXIN TYPE A vs BRENTUXIMAB VEDOTIN
BOTULINUM TOXIN TYPE A vs BREO ELLIPTA
BOTULINUM TOXIN TYPE A vs BREXANOLONE